John R. Mascola
John R. Mascola | |
|---|---|
| Nationality | American |
| Known for | HIV research, Vaccine development |
| Scientific career | |
| Fields | Immunology, Virology |
| Institutions | National Institutes of Health |
John R. Mascola is an American immunologist and virologist known for his significant contributions to HIV research and vaccine development. He has held prominent positions at the National Institutes of Health (NIH), where he has been instrumental in advancing the understanding of viral infections and the human immune response.
Education and Early Career[edit | edit source]
Mascola received his medical degree from the Georgetown University School of Medicine. He completed his residency in internal medicine at the New England Deaconess Hospital and a fellowship in infectious diseases at the National Institute of Allergy and Infectious Diseases (NIAID).
Research Contributions[edit | edit source]
Mascola's research has primarily focused on the development of vaccines for HIV and other infectious diseases. He has been a leading figure in the study of broadly neutralizing antibodies (bNAbs) against HIV, which are crucial for the development of an effective HIV vaccine. His work has significantly contributed to the understanding of how these antibodies can neutralize a wide range of HIV strains.
Leadership Roles[edit | edit source]
At the National Institutes of Health, Mascola has served in various leadership roles, including the Director of the Vaccine Research Center (VRC) at NIAID. Under his leadership, the VRC has made significant strides in the development of vaccines for HIV, influenza, and other emerging infectious diseases.
Awards and Honors[edit | edit source]
Mascola has received numerous awards and honors for his contributions to medical research, including recognition from professional organizations and institutions dedicated to the study of infectious diseases and immunology.
Personal Life[edit | edit source]
Mascola resides in the United States and continues to be actively involved in research and public health initiatives.
See Also[edit | edit source]
- HIV vaccine
- Broadly neutralizing antibodies
- National Institute of Allergy and Infectious Diseases
- Vaccine Research Center
References[edit | edit source]
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
